Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-24-019110
Filing Date
2024-11-14
Accepted
2024-11-14 16:00:05
Documents
1
Group Members
CONCENTRA BIOSCIENCES, LLCKEVIN TANGTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 okur1015243sc13ga1.htm SC 13G/A 102775
  Complete submission text file 0001214659-24-019110.txt   104584
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001232621 (see all company filings)

EIN.: 461592449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Subject) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92480 | Film No.: 241461364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)